These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2962095)

  • 1. [Nephrotoxicity of pristinamycin-cyclosporin interaction in renal transplant patients].
    Gagnadoux MF; Loirat C; Pillion G; Bertheleme JP; Pouliquen M; Guest G; Broyer M
    Presse Med; 1987 Oct; 16(35):1761. PubMed ID: 2962095
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential diagnosis of rejection and cyclosporin nephrotoxicity in organ transplantation using exfoliative urinary cytology].
    Stella F; Alfani D; Stella C; Battistelli S; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1985 Sep; 21(3):330-40. PubMed ID: 3915106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Nephrotoxicity' and metabolic acidosis in transplant patients on cyclosporin A.
    Hamilton DV; Evans DB; Henderson RG; Thiru S; Calne RY; White DJ; Carmichael DJ
    Proc Eur Dial Transplant Assoc; 1981; 18():400-9. PubMed ID: 7036160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclosporin-induced nephrotoxicity].
    Heering P; Grabensee B
    Dtsch Med Wochenschr; 1988 May; 113(20):833-4. PubMed ID: 3286182
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood pharmacokinetic parameters of cyclosporin A and nephrotoxicity. Diagnostic and predictive value in renal transplantation].
    Serre-Debeauvais F; Benzekri S; Alix JL; Vialtel P; Gavend M
    Therapie; 1988; 43(1):9-13. PubMed ID: 3282342
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine.
    Thompson JF; Chalmers DH; Hunnisett AG; Wood RF; Morris PJ
    Transplantation; 1983 Aug; 36(2):204-6. PubMed ID: 6349046
    [No Abstract]   [Full Text] [Related]  

  • 7. Magnetic resonance imaging of renal transplants: its value in the differentiation of acute rejection and cyclosporin A nephrotoxicity.
    te Strake L; Schultze Kool LJ; Paul LC; Tegzess AM; Weening JJ; Hermans J; Doornbos J; Bluemm RG; Bloem JL
    Clin Radiol; 1988 May; 39(3):220-8. PubMed ID: 3293883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of cyclosporin nephrotoxicity by diuretic therapy.
    Deray G; Baumelou B; Le Hoang P; Aupetit B; Girard B; Baumelou A; Legrand JC; Jacobs C
    Clin Nephrol; 1989 Jul; 32(1):47. PubMed ID: 2758701
    [No Abstract]   [Full Text] [Related]  

  • 9. Does nifedipine ameliorate cyclosporin A nephrotoxicity?
    Kwan JT; Foxall PJ; Townend JN; Bending MR; Eisinger AJ
    Br Med J (Clin Res Ed); 1987 Oct; 295(6602):851. PubMed ID: 3119066
    [No Abstract]   [Full Text] [Related]  

  • 10. Does nifedipine ameliorate cyclosporin A nephrotoxicity?
    Feehally J; Walls J; Mistry N; Horsburgh T; Taylor J; Veitch PS; Bell PR
    Br Med J (Clin Res Ed); 1987 Aug; 295(6593):310. PubMed ID: 3115427
    [No Abstract]   [Full Text] [Related]  

  • 11. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular lesions as manifestations of cyclosporin nephrotoxicity.
    Moody H; Matz L; Hurst P
    Lancet; 1986 May; 1(8491):1221-2. PubMed ID: 2871465
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute ciclosporin nephrotoxicity in renal transplant patients.
    Carmellini M; Di Stefano R; Pietrabissa A; Oleggini M; Rizzo G; Rindi P; Palla R; Mosca F
    Contrib Nephrol; 1990; 83():213-5. PubMed ID: 2100714
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of fractional excretion of sodium as index of cyclosporine nephrotoxicity in renal transplantation.
    Morales JM; Andres A; Alcazar JM; Prieto C; Diaz de Tueste I; Ruilope LM; Rodicio JL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):691-9. PubMed ID: 3291305
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary cytologic abnormalities in bone marrow transplant recipients of cyclosporin.
    Stella F; Troccoli R; Stella C; Battistelli S; Biagioni S; Giardini C; Baronciani D; Manenti F
    Acta Cytol; 1987; 31(5):615-9. PubMed ID: 3314304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Itraconazole and cyclosporin nephrotoxicity.
    Nováková I; Donnelly P; de Witte T; de Pauw B; Boezeman J; Veltman G
    Lancet; 1987 Oct; 2(8564):920-1. PubMed ID: 2889119
    [No Abstract]   [Full Text] [Related]  

  • 17. Histological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants.
    Versluis DJ; Ten Kate FJ; Wenting GJ; Jeekel J; Weimar W
    J Clin Pathol; 1988 May; 41(5):498-503. PubMed ID: 3290264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biopsy findings in kidney transplants after treatment with cyclosporin A].
    Nizze H; Gokel JM; Lang W; Mihatsch MJ
    Zentralbl Allg Pathol; 1986; 132(5-6):423-33. PubMed ID: 3551394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide.
    Quarto Di Palo F; Elli A; Rivolta R; Parenti M; Palazzi P; Zanussi C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):969-71. PubMed ID: 1989347
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of 99Tcm radionuclides to show nephrotoxicity of cyclosporin A in transplanted kidneys.
    Thomsen HS; Munck O
    Acta Radiol; 1987; 28(1):59-61. PubMed ID: 3032224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.